Kore Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Kore Private Wealth's BMY Position: Q3 2022 in Review
Kore Private Wealth reduced its Bristol-Myers Squibb (BMY) stake by 8% in Q3 2022, selling an estimated $37.4K and leaving 5,956 shares worth $423K. The position accounts for 0.08% of the portfolio, ranked #148.
Kore Private Wealth first reported a position in BMY in Q4 2018 and has held it in 16 quarters since. The position peaked at $498K in Q2 2022. 2,470 funds tracked by Wall St. Rank hold BMY as of Q3 2022.
- Kore Private Wealth held 5,956 shares of Bristol-Myers Squibb worth $423K as of Q3 2022.
- Kore Private Wealth sold 515 Bristol-Myers Squibb shares in Q3 2022, an estimated $37.4K.
- Bristol-Myers Squibb made up 0.08% of Kore Private Wealth's portfolio in Q3 2022, its #148 holding.
- Kore Private Wealth first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 16 quarters since.
- Kore Private Wealth's Bristol-Myers Squibb position peaked at $498K in Q2 2022.
- 2,470 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.
Based on Kore Private Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.